Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid na... Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology. Show more
WARMINSTER, Pa., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (โArbutusโ or the โCompanyโ), a clinical-stage biopharmaceutical company leveraging its extensive...
End-of-treatment data presented at the EASL Congress from two Phase 2a clinical trials supports advancing imdusiran as a potential cornerstone in a HBV functional cure treatment regimen IM-PROVE I...
WARMINSTER, Pa., July 18, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop...
Data highlighted in oral presentation at the European Association for the Study of the Liver (EASL) Congress WARMISTER, Pa., June 06, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.25 | -5.85480093677 | 4.27 | 4.3199 | 3.9631 | 2619692 | 4.05184609 | CS |
4 | 0.15 | 3.87596899225 | 3.87 | 4.725 | 3.79 | 1780643 | 4.19090734 | CS |
12 | 0.9 | 28.8461538462 | 3.12 | 4.725 | 3.05 | 1174011 | 3.93144754 | CS |
26 | 1.51 | 60.1593625498 | 2.51 | 4.725 | 2.3 | 1212747 | 3.43124282 | CS |
52 | 2.09 | 108.29015544 | 1.93 | 4.725 | 1.69 | 1015709 | 2.99227185 | CS |
156 | -0.48 | -10.6666666667 | 4.5 | 6.5 | 1.69 | 1816587 | 3.5155409 | CS |
260 | 2.42 | 151.25 | 1.6 | 9 | 0.81 | 2122509 | 3.68630196 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.